BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29401167)

  • 1. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.
    Jeon CY; Li D; Cleary S; Stolzenberg-Solomon R; Bosetti C; La Vecchia C; Porta M; Toriola AT; Hung RJ; Kurtz RC; Olson SH
    Pancreas; 2018 Mar; 47(3):314-320. PubMed ID: 29401167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study.
    Imaoka H; Shimizu Y; Mizuno N; Hara K; Hijioka S; Tajika M; Kondo S; Tanaka T; Ogura T; Obayashi T; Hasegawa T; Niwa Y; Yamao K
    Pancreas; 2014 Mar; 43(2):287-90. PubMed ID: 24518509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening.
    Hur C; Tramontano AC; Dowling EC; Brooks GA; Jeon A; Brugge WR; Gazelle GS; Kong CY; Pandharipande PV
    Pancreas; 2016 Aug; 45(7):1062-6. PubMed ID: 26692444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus.
    Ben Q; Xu M; Jiang Y; Yuan Y; Wang K; Fang J; Li Z
    Diabetes Metab Res Rev; 2012 Feb; 28(2):169-76. PubMed ID: 22423386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
    van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
    Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms.
    Yamada S; Fujii T; Hirakawa A; Takami H; Suenaga M; Hayashi M; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Pancreas; 2018 Sep; 47(8):974-979. PubMed ID: 30028445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
    Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
    PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.
    Ansari D; Bauden M; Bergström S; Rylance R; Marko-Varga G; Andersson R
    Br J Surg; 2017 Apr; 104(5):600-607. PubMed ID: 28177521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
    Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
    J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.